TALazoparib and Avelumab as Maintenance Therapy in Platinum-Sensitive Metastatic or Locally Advanced URothelial Carcinoma
Clinical trial NCT04678362 · RECRUITING
Trial details
- NCT number
- NCT04678362
- Sponsor
- Centre Francois Baclesse
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-06-01
- Primary completion
- 2023-07-28
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.